These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Inhaled salbutamol and endurance cycling performance in non-asthmatic athletes. van Baak MA, de Hon OM, Hartgens F, Kuipers H. Int J Sports Med; 2004 Oct; 25(7):533-8. PubMed ID: 15459835 [Abstract] [Full Text] [Related]
3. Prevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of salmeterol powder with albuterol. Blake K, Pearlman DS, Scott C, Wang Y, Stahl E, Arledge T. Ann Allergy Asthma Immunol; 1999 Feb; 82(2):205-11. PubMed ID: 10071526 [Abstract] [Full Text] [Related]
4. Endurance shuttle walking test: responsiveness to salmeterol in COPD. Brouillard C, Pepin V, Milot J, Lacasse Y, Maltais F. Eur Respir J; 2008 Mar; 31(3):579-84. PubMed ID: 18057052 [Abstract] [Full Text] [Related]
5. A twelve month comparison of salmeterol with salbutamol in asthmatic patients. European Study Group. Britton MG, Earnshaw JS, Palmer JB. Eur Respir J; 1992 Oct; 5(9):1062-7. PubMed ID: 1426215 [Abstract] [Full Text] [Related]
6. Bronchoprotection by salmeterol: cell stabilization or functional antagonism? Comparative effects on histamine- and AMP-induced bronchoconstriction. Solèr M, Joos L, Bolliger CT, Elsasser S, Perruchoud AP. Eur Respir J; 1994 Nov; 7(11):1973-7. PubMed ID: 7875267 [Abstract] [Full Text] [Related]
7. Can asthma treatment in sports be doping? The effect of the rapid onset, long-acting inhaled beta2-agonist formoterol upon endurance performance in healthy well-trained athletes. Carlsen KH, Hem E, Stensrud T, Held T, Herland K, Mowinckel P. Respir Med; 2001 Jul; 95(7):571-6. PubMed ID: 11453313 [Abstract] [Full Text] [Related]
8. Dose-response study of inhaled salmeterol in asthmatic patients with 24-hour spirometry and Holter monitoring. Kemp JP, Bierman CW, Cocchetto DM. Ann Allergy; 1993 Apr; 70(4):316-22. PubMed ID: 8466097 [Abstract] [Full Text] [Related]
9. Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction. Lindberg A, Szalai Z, Pullerits T, Radeczky E. Respirology; 2007 Sep; 12(5):732-9. PubMed ID: 17875063 [Abstract] [Full Text] [Related]
10. Salmeterol and physical performance at -15 degrees C in highly trained nonasthmatic cross-country skiers. Sue-Chu M, Sandsund M, Helgerud J, Reinertsen RE, Bjermer L. Scand J Med Sci Sports; 1999 Feb; 9(1):48-52. PubMed ID: 9974197 [Abstract] [Full Text] [Related]
11. Effect of fluticasone/salmeterol administered via a single device on exercise-induced bronchospasm in patients with persistent asthma. Weiler JM, Nathan RA, Rupp NT, Kalberg CJ, Emmett A, Dorinsky PM. Ann Allergy Asthma Immunol; 2005 Jan; 94(1):65-72. PubMed ID: 15702819 [Abstract] [Full Text] [Related]
12. Comparison of bronchodilator responses of levosalbutamol and salbutamol given via a pressurized metered dose inhaler: a randomized, double blind, single-dose, crossover study. Jantikar A, Brashier B, Maganji M, Raghupathy A, Mahadik P, Gokhale P, Gogtay J, Salvi S. Respir Med; 2007 Apr; 101(4):845-9. PubMed ID: 17276051 [Abstract] [Full Text] [Related]
13. Effects of regular salmeterol on lung function and exercise capacity in patients with chronic obstructive airways disease. Grove A, Lipworth BJ, Reid P, Smith RP, Ramage L, Ingram CG, Jenkins RJ, Winter JH, Dhillon DP. Thorax; 1996 Jul; 51(7):689-93. PubMed ID: 8882074 [Abstract] [Full Text] [Related]
14. Inhaled beta-agonists improve lung function but not maximal exercise capacity in cystic fibrosis. Dodd JD, Barry SC, Daly LE, Gallagher CG. J Cyst Fibros; 2005 May; 4(2):101-5. PubMed ID: 15978535 [Abstract] [Full Text] [Related]
15. [The influence of salmeterol and salbutamol on bronchial constriction in patients with bronchial asthma]. Tymińska K, Grzelewska-Rzymowska I, Kroczyńska-Bednarek J, Kwiatkowska S. Pneumonol Alergol Pol; 1998 May; 66(11-12):524-9. PubMed ID: 10391959 [Abstract] [Full Text] [Related]
16. Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma. Cheung D, Timmers MC, Zwinderman AH, Bel EH, Dijkman JH, Sterk PJ. N Engl J Med; 1992 Oct 22; 327(17):1198-203. PubMed ID: 1357550 [Abstract] [Full Text] [Related]
17. Efficacy and safety of single therapeutic and supratherapeutic doses of indacaterol versus salmeterol and salbutamol in patients with asthma. Brookman LJ, Knowles LJ, Barbier M, Elharrar B, Fuhr R, Pascoe S. Curr Med Res Opin; 2007 Dec 22; 23(12):3113-22. PubMed ID: 17999782 [Abstract] [Full Text] [Related]
18. Effect of long-term salmeterol treatment on exercise-induced asthma. Nelson JA, Strauss L, Skowronski M, Ciufo R, Novak R, McFadden ER. N Engl J Med; 1998 Jul 16; 339(3):141-6. PubMed ID: 9664089 [Abstract] [Full Text] [Related]
19. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma. Pearlman DS, Stricker W, Weinstein S, Gross G, Chervinsky P, Woodring A, Prillaman B, Shah T. Ann Allergy Asthma Immunol; 1999 Mar 16; 82(3):257-65. PubMed ID: 10094216 [Abstract] [Full Text] [Related]
20. Efficacy and duration of salmeterol powder inhalation in protecting against exercise-induced bronchoconstriction. Schaanning J, Vilsvik J, Henriksen AH, Bratten G. Ann Allergy Asthma Immunol; 1996 Jan 16; 76(1):57-60. PubMed ID: 8564629 [Abstract] [Full Text] [Related] Page: [Next] [New Search]